218 related articles for article (PubMed ID: 23970381)
41. Voriconazole prophylaxis in leukemic patients: A retrospective single-center study.
Bui V; Walker SA; Elligsen M; Vyas A; Kiss A; Palmay L
J Oncol Pharm Pract; 2020 Jun; 26(4):873-881. PubMed ID: 31566111
[TBL] [Abstract][Full Text] [Related]
42. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Cornely OA; Maertens J; Winston DJ; Perfect J; Ullmann AJ; Walsh TJ; Helfgott D; Holowiecki J; Stockelberg D; Goh YT; Petrini M; Hardalo C; Suresh R; Angulo-Gonzalez D
N Engl J Med; 2007 Jan; 356(4):348-59. PubMed ID: 17251531
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China.
Xu XH; Zhang L; Cao XX; Li J; Zhang W; Zhu TN; Cai HC; Chen M; Han X; Yang C; Han B; Zhang Y; Zhuang JL; Zhou DB; Duan MH
J Infect Chemother; 2017 Jun; 23(6):360-367. PubMed ID: 28341518
[TBL] [Abstract][Full Text] [Related]
44. Incidence and management of proven and probable fungal infections in patients with acute leukemia: a single center experience.
Fanci R; Casini C; Leoni F; Ciolli S; Bosi A
J Chemother; 2004 Dec; 16(6):557-60. PubMed ID: 15700847
[TBL] [Abstract][Full Text] [Related]
45. SEIFEM 2010-E: economic evaluation of posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia receiving induction chemotherapy.
Busca A; Lessi F; Verga L; Candoni A; Cattaneo C; Cesaro S; Dragonetti G; Delia M; De Luca A; Guglielmi G; Tumbarello M; Martino G; Nadali G; Fanci R; Picardi M; Potenza L; Nosari A; Aversa F; Pagano L;
Leuk Lymphoma; 2017 Dec; 58(12):2859-2864. PubMed ID: 28508692
[TBL] [Abstract][Full Text] [Related]
46. Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience.
Girmenia C; Frustaci AM; Gentile G; Minotti C; Cartoni C; Capria S; Trisolini SM; Matturro A; Loglisci G; Latagliata R; Breccia M; Meloni G; Alimena G; Foà R; Micozzi A
Haematologica; 2012 Apr; 97(4):560-7. PubMed ID: 22102706
[TBL] [Abstract][Full Text] [Related]
47. Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia.
Torres A; Serrano J; Rojas R; Martín V; Martín C; Tabares S; Molina JR; Capote M; Martínez F; Gómez P; Sánchez-García J
Eur J Haematol; 2010 Mar; 84(3):271-3. PubMed ID: 19878274
[No Abstract] [Full Text] [Related]
48. Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.
Doan TN; Kirkpatrick CM; Walker P; Slavin MA; Ananda-Rajah MR; Morrissey CO; Urbancic KF; Grigg A; Spencer A; Szer J; Seymour JF; Kong DC
J Antimicrob Chemother; 2016 Feb; 71(2):497-505. PubMed ID: 26518050
[TBL] [Abstract][Full Text] [Related]
49. Fungal infections in pediatric patients with acute myeloid leukemia in a tertiary hospital.
Ávila Montiel D; Saucedo Campos A; Avilés Robles M; Murillo Maldonado MA; Jiménez Juárez R; Silva Dirzo M; Dorantes Acosta E
Front Public Health; 2023; 11():1056489. PubMed ID: 37033052
[TBL] [Abstract][Full Text] [Related]
50. Clinical characteristics and outcome of invasive fungal infections in pediatric acute myeloid leukemia patients in a medical center in Taiwan.
Lin GL; Chang HH; Lu CY; Chen CM; Lu MY; Lee PI; Jou ST; Yang YL; Huang LM; Chang LY
J Microbiol Immunol Infect; 2018 Apr; 51(2):251-259. PubMed ID: 28089099
[TBL] [Abstract][Full Text] [Related]
51. High incidence of invasive fungal infection during acute myeloid leukemia treatment in a resource-limited country: clinical risk factors and treatment outcomes.
Nganthavee V; Phutthasakda W; Atipas K; Tanpong S; Pungprasert T; Dhirachaikulpanich D; Krithin S; Tanglitanon S; Jutidamronphang W; Owattanapanich W; Chayakulkeeree M; Phikulsod P
Support Care Cancer; 2019 Sep; 27(9):3613-3622. PubMed ID: 31165931
[TBL] [Abstract][Full Text] [Related]
52. [Economic evaluation of posaconazole in prophylaxis of invasive fungal infections in Italian neutropenic patients with acute myeloid leukaemia or myelodysplastic syndrome].
Lazzaro C
Infez Med; 2010 Jun; 18(2):91-103. PubMed ID: 20610931
[TBL] [Abstract][Full Text] [Related]
53. A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia.
Getz KD; Miller TP; Seif AE; Li Y; Huang YS; Bagatell R; Fisher BT; Aplenc R
Cancer Med; 2015 Sep; 4(9):1356-64. PubMed ID: 26105201
[TBL] [Abstract][Full Text] [Related]
54. Incidence and outcomes of invasive fungal disease in adult patients with acute lymphoblastic leukemia treated with hyperfractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone: implications for prophylaxis.
Henden A; Morris K; Truloff N; Nakagaki M; Kennedy GA
Leuk Lymphoma; 2013 Jun; 54(6):1329-31. PubMed ID: 23072370
[No Abstract] [Full Text] [Related]
55. Microbiologically documented fungal infections in pediatric patients with acute myeloid leukemia: 12.5-year experience at a single institution.
Agarwal V; Joyce M
J Pediatr Hematol Oncol; 2014 Nov; 36(8):e528-32. PubMed ID: 24824444
[TBL] [Abstract][Full Text] [Related]
56. Incidence of bacteremias and invasive mycoses in children with acute non-lymphoblastic leukemia: results from a multi-center Italian study.
Castagnola E; Rossi MR; Cesaro S; Livadiotti S; Giacchino M; Zanazzo G; Fioredda F; Beretta C; Ciocchello F; Carli M; Putti MC; Pansini V; Berger M; Licciardello M; Farina S; Caviglia I; Haupt R
Pediatr Blood Cancer; 2010 Dec; 55(6):1103-7. PubMed ID: 20680968
[TBL] [Abstract][Full Text] [Related]
57. Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia.
Yeh TC; Hou JY; Huang TH; Lu CH; Sun FJ; Huang HM; Liu HC
Sci Rep; 2021 Oct; 11(1):21142. PubMed ID: 34707164
[TBL] [Abstract][Full Text] [Related]
58. Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India.
Rajendranath R; Balasubramaniyum VK; Vijayakumar V; Ganesan P; Tenali GS
Indian J Cancer; 2014; 51(4):481-6. PubMed ID: 26842171
[TBL] [Abstract][Full Text] [Related]
59. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
60. A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
Welte K; Reiter A; Mempel K; Pfetsch M; Schwab G; Schrappe M; Riehm H
Blood; 1996 Apr; 87(8):3143-50. PubMed ID: 8605328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
